In conclusion, our meta-analysis demonstrated the beneficial effect of ALA supplementation on reducing CRP, TNF-α, SBP, and TG in individuals with obesity or overweight. This evidence concerns the gene CRP and obesity due to melanocortin 4 receptor deficiency.